Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins

被引:83
作者
Park, CT
Wright, SD
机构
[1] ROCKEFELLER UNIV, CELLULAR PHYSIOL & IMMUNOL LAB, NEW YORK, NY 10021 USA
[2] MEM SLOAN KETTERING CANC CTR, DEPT PEDIAT, NEW YORK, NY 10021 USA
关键词
D O I
10.1074/jbc.271.30.18054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neutrophils exhibit a dramatic enhancement of integrin-mediated cell adhesion in response to lipopolysaccharide (LPS). This response requires CD14 on the neutrophil and plasma proteins in solution, We have purified the factor from plasma that facilitates the adhesive response of neutrophil to LPS by using a combination of affinity and ion-exchange chromatography. Previous work has shown that the activity is associated with apolipoprotein A-I (apoA-I), and here we show that this activity is associated with an apoA-I-bearing complex of protein and phospholipid, Native polyacrylamide gel electrophoresis (PAGE) analysis showed a ladder of bands in the M(r) 200,000 region, and electron microscopy revealed round, indented particles of 11.4 +/- 0.12 nm in diameter. Characterization of these particles revealed a density of 1.219-1.264 g/ml and similar to 10 molecules of lipid phosphate per M(r) 200,000 complex, SDS-PAGE showed that each of the bands seen in native PAGE was composed of several polypeptides. These were identified as apoA-I, LPS binding protein (LBP), and factor H-related proteins (FHRPs), Physical association of apoA-I, LBP, and FHRP in these particles was further confirmed using double immunodiffusion, and association of LBP and FHRP in plasma was confirmed by coimmunoprecipitation, FHRPs are the numerically dominant protein components in these particles, and all plasma FHRP-1 appears to be associated with these particles. We suggest that FHRPs may be the defining constituent of this novel ''lipoprotein'' particle.
引用
收藏
页码:18054 / 18060
页数:7
相关论文
共 40 条
[1]  
AMES BN, 1960, J BIOL CHEM, V235, P769
[2]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]  
CALVANO SE, 1994, ARCH SURG-CHICAGO, V129, P220
[4]  
DARR WH, 1985, J LIPID RES, V26, P672
[5]  
DAY JR, 1994, J BIOL CHEM, V269, P9388
[6]  
DESILVA HV, 1990, J BIOL CHEM, V265, P13240
[7]  
DETMERS PA, 1994, J IMMUNOL, V153, P2137
[8]  
ESTALLER C, 1991, J IMMUNOL, V146, P3190
[9]   TRUNCATED FORMS OF HUMAN-COMPLEMENT FACTOR-H [J].
FONTAINE, M ;
DEMARES, MJ ;
KOISTINEN, V ;
DAY, AJ ;
DAVRINCHE, C ;
SIM, RB ;
RIPOCHE, J .
BIOCHEMICAL JOURNAL, 1989, 258 (03) :927-930
[10]  
FORTE TM, 1986, METHOD ENZYMOL, V128, P442